PARP1 hyperactivation: mechanisms and cellular consequences
Biochemical Society Transactions · 25.11.2026 · 54 (11) · 1635-1649
DOI: 10.1042/bst20260683 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 12.11.2026. Verfasst von Pedro Ortega und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, U.S.A. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Poly(ADP-ribose) polymerase 1 (PARP1) is a key DNA-damage sensor that promotes DNA repair by synthesizing poly(ADP-ribose) (PAR), which recruits repair factors, chromatin regulators, and other PAR-binding proteins to DNA lesions. Because PAR shares structural features with RNA, it can engage RNA-binding domains and compete with RNA for common binding surfaces, extending PARP1 signaling beyond DNA repair to regulate RNA-binding proteins (RBPs) and RNA biogenesis. Here, we discuss the mechanisms that drive PARP1 hyperactivation and highlight how excessive PAR synthesis disrupts RNA metabolism, biomolecular condensation, and protein synthesis. Although PARP1 responds to a broad range of DNA damage, the magnitude of its activation is determined by lesion identity rather than overall DNA damage levels. Mechanistically, distinct forms of genotoxic stress, including alkylation, oxidative stress, and ATR inhibition, converge on the generation of abasic sites that APE1 cleaves during base excision repair, producing DNA breaks with 5′-deoxyribose phosphate termini that hyperactivate PARP1. High PAR levels disrupt RBP–RNA interactions, impair RNA export and splicing, and promote aberrant nuclear condensate formation, depleting cytoplasmic mRNA and suppressing translation. In parallel, sustained PARP1 hyperactivation can drive NAD+ and ATP depletion and promote parthanatos, a PARP1-dependent form of regulated cell death implicated in neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, U.S.A.
- Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, Irvine, CA, U.S.A.
ORCID-Profile: Pedro Ortega, Rémi Buisson
Förderung
- NIEHS NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- NIH
Zitieren
APA
Ortega, P., & Buisson, R. (2026). PARP1 hyperactivation: mechanisms and cellular consequences. Biochemical Society Transactions, 54(11), 1635-1649. https://doi.org/10.1042/bst20260683
Vancouver
Ortega P, Buisson R. PARP1 hyperactivation: mechanisms and cellular consequences. Biochemical Society Transactions. 2026;54(11):1635-1649. doi:10.1042/bst20260683
BibTeX
@article{Ortega2026,
author = {Ortega, Pedro and Buisson, Rémi},
title = {PARP1 hyperactivation: mechanisms and cellular consequences},
journal = {Biochemical Society Transactions},
year = {2026},
volume = {54},
number = {11},
pages = {1635--1649},
doi = {10.1042/bst20260683}
}
EUVIMED